Presidents


Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy



Bernard A. Fox

Bernard A. Fox
Chief of the Laboratory of Molecular and Tumor Immunology, Oregon Health and Science University, Providence Cancer Center, Portland Medical Center, Oregon



Francesco M. Marincola

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar





Scientific Board


Sanjiv Agarwala

Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania



Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy



Gennaro Ciliberto

Gennaro Ciliberto
Scientific Director of the National Cancer Institute “Fondazione G. Pascale” of Naples, Italy




Reinhard Dummer

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland




Bernard A. Fox

Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon



Claus Garbe

Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany



Francesco M. Marincola

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar




Giuseppe Masucci

Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden



Nicola Mozzillo

Nicola Mozzillo
Director of the Department Melanoma and Soft Tissues, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy



Michael Postow

Michael Postow
Memorial Sloan Kettering Cancer Center, New York




Igor Puzanov

Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY




Magdalena Thurin

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland



Ena Wang

Ena Wang
Division Chief of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar




Tara Withington

Tara Withington
Executive Director, Society for Immunotherapy of Cancer, Milwaukee

 


For information please contact info@melanomabridge.org